脑部放疗，上午比下午敏感许多！1 I& p( B ^; ^- S& l- b# p
! n$ N* F: |2 C& Q% y. r
2 f3 M. P9 k" X Y6 u& q* _$ a: ]) L
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
. G! s: ^: L6 X) nGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?% S& t& ]) B6 n/ e; o _9 a
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
0 m2 B* s, g, p8 lSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.4 g, o5 h7 u9 ] E L
. Y4 l/ g7 V& m) V4 b# r. y, W8 DAbstract
2 x0 }# |/ t6 V- zBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
$ P: E8 p3 u$ } w+ G2 v
. T S; X; V: b# X. s7 aMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.. Y2 n3 o' o3 r; M7 h
X- L5 j' |# T, NRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
9 y: F1 T4 ~8 q& C! u$ ?; a7 A- `/ c$ {5 Y8 Z5 ?' s; d) R3 y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.; N% M5 a1 ] ~
2 n7 I" b5 {9 Y' w( r+ Y. h |
显身卡
